Multiple myeloma Clinical Trials in New York, NY

As of September 2026, 41 paid clinical trials are recruiting for Multiple myeloma in New York, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Related specialties in New York

Oncology· 1,370Blood cancer· 258
Filter results
Filter results
Recruitment status
Phase
Sex
Age

41 clinical trials for Multiple myeloma

·Clear filters·
Email me when a new multiple myeloma trial opens in New York, NY.

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma
Drug: Belantamab mafodotin
Sites in New York, Stony Brook +28 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024
Apply to this trial